
|Videos|August 17, 2016
Matthew Galsky on Treating Different Subsets of Bladder Cancer
Author(s)Matthew Galsky, MD
Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treating different subsets of bladder cancer.
Advertisement
Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treating different subsets of bladder cancer.
The most common type of bladder cancer, non muscle invasive, is highly curable with standard treatment. Cure still remains a possibility as the cancer spreads to the muscle later, though there is an increased chance of further spread. Then as the cancer spreads to regional lymph nodes and then becomes distant metastatic disease, the potential for cure decreases, but Galsky is hopeful that the developments of new targets will offer more options to these patients.
Advertisement
Related Content
Advertisement




First-Line Treatment Choice and Altering Resistance in EGFR-Mutant NSCLC
Published: | Updated:

Latest CME
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer
2
Thoracic Oncology Advances and Toxicity Management
3
FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses
4
ASCO Releases First Living Guideline for Recurrent Ovarian Cancer Care
5










































